Skip to content

Correlation Between Serum Progesterone Level And Primary Dysmenorrhea

Correlation Between Serum Progesterone Level And Menstrual Symptoms In Young Females With Primary Dysmenorrhea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06359457
Enrollment
100
Registered
2024-04-11
Start date
2024-05-05
Completion date
2024-12-31
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea

Keywords

Dysmenorrhoea, Serum progesterone level, Visual analogue scale, Menstrual symptoms questionnaire

Brief summary

This study will be conducted to determine the correlation between the levels of serum progesterone and Menstrual Symptoms In Young Females with primary dysmenorrhea.

Detailed description

One hundred adult females with primary dysmenorrhea will participate in this study. They will be recruited from the Gynaecological outpatient clinic, Kasr El Ainy University Hospital, Cairo, Egypt Many studies reported that primary dysmenorrhea was the result of increased prostaglandin, especially prostaglandin F2α (PGF2α) and prostaglandin E2 (PGE2) which produced the effect through the cyclooxygenase pathway, and further led to uterine ischemia hypoxia. Nevertheless the relationship between the serum progesterone level and menstrual symptoms was not completely clear. Hence, this study will investigate the association between the serum progesterone level and menstrual symptoms in young females with primaryf dysmenorrhea.

Interventions

None listed

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
17 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

1. One hundreds adult females were suffered from primary dysmenorrhea. 2. Their age was ranged from 17 to 24 years. 3. Their body mass index was ranged from 20 to 25 kg/m2.

Exclusion criteria

* Any participant will be excluded from the study if they have: 1. Irregulars or infrequent menstrual cycles. 2. Pacemaker, Myasthenia gravis, hyperthyroidism, active tuberculosis and psychosis. 3. Pelvic pathology.

Design outcomes

Primary

MeasureTime frameDescription
Serum progesterone level1 monthBlood samples will be taken by physician for each girl, and will send to laboratory center to measure the progesterone level in the blood. The normal serum progesterone level at 21st day is 4-20 ng
Pain intensity1 monthIt will be measured by Visual analogue scale. It is 10 cm line with values ranging from 0 to 10. 0 indicates no pain nd 10 indicates the worst pain.
Physical and psychological menstrual symptoms1 monthIt will be measured by menstrual symptoms questionnaire. It is 25 items split into two categories which used to assess the physical and psychological symptoms associated with dysmenorrhea. The score on each item ranged from 1 (never) to 5 (always) with a higher composite score indicating more symptoms
Correlation between serum progesterone level and pain1 monthThe correlation between serum progesterone level and pain intensity measured by the VAS will be conducted
Correlation between serum progesterone level and menstrual symptoms1 monthThe correlation between serum progesterone level and menstrual symptoms measured by the menstrual symptom questionnaire will be conducted

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026